Trial Profile
An open label, randomised study investigating efficacy and safety of Vonoprazan in triple therapy for eradication of Helicobacter pylori infection
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 Dec 2016
Price :
$35
*
At a glance
- Drugs Vonoprazan (Primary) ; Amoxicillin; Clarithromycin; Esomeprazole
- Indications Helicobacter infections
- Focus Therapeutic Use
- 15 Dec 2016 New trial record
- 19 Oct 2016 Interim results (n=100) presented at the 24th United European Gastroenterology Week.